AAAAAA
Results:
1-24
|
Results: 24
Authors:
Manning, M
Stoev, S
Cheng, LL
Wo, NC
Chan, WY
Citation: M. Manning et al., Design of oxytocin antagonists, which are more selective than Atosiban, J PEPT SCI, 7(9), 2001, pp. 449-465
Authors:
Manning, M
Hartmuth, S
Weidner, W
Alken, P
Junemann, KP
Citation: M. Manning et al., Testosterone reaction after testicular biopsies - further investigation inthe normogonad and cryptorchid rat model, UROL RES, 29(3), 2001, pp. 173-177
Authors:
Steger, K
Failing, K
Klonisch, T
Behre, HM
Manning, M
Weidner, W
Hertle, L
Bergmann, M
Kliesch, S
Citation: K. Steger et al., Round spermatids from infertile men exhibit decreased protamine-1 and-2 mRNA, HUM REPR, 16(4), 2001, pp. 709-716
Authors:
Manning, M
Lissens, W
Liebaers, I
Van Steirteghem, A
Weidner, W
Citation: M. Manning et al., Imprinting analysis in spermatozoa prepared for intracytoplasmic sperm injection (ICSI), INT J ANDR, 24(2), 2001, pp. 87-94
Authors:
Manning, M
Lissens, W
Weidner, W
Liebaers, I
Citation: M. Manning et al., DNA methylation analysis in immature testicular sperm cells at different developmental stages, UROL INTERN, 67(2), 2001, pp. 151-155
Authors:
Chan, WY
Levi, R
Wo, NC
Koyama, M
Stoev, S
Cheng, LL
Manning, M
Citation: Wy. Chan et al., Novel selective hypotensive vasopressin peptides: cardiovascular and structure-activity-relationship studies, EUR J PHARM, 419(1), 2001, pp. 65-72
Authors:
Manning, M
Citation: M. Manning, How to select a power supply, ELECTR PROD, 43(10), 2001, pp. 37-38
Authors:
Manning, M
Lissens, W
Bonduelle, M
Camus, M
De Rijcke, M
Liebaers, I
Van Steirteghem, A
Citation: M. Manning et al., Study of DNA-methylation patterns at chromosome 15q11-q13 in children bornafter ICSI reveals no imprinting defects, MOL HUM REP, 6(11), 2000, pp. 1049-1053
Authors:
Chan, WY
Wo, NC
Stoev, S
Cheng, LL
Manning, M
Citation: Wy. Chan et al., Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays, EXP PHYSIOL, 85, 2000, pp. 7S-18S
Authors:
Bregazzi, VS
Dernell, WS
Huber, DJ
Schochet, R
Lafferty, M
Ogilvie, GK
Withrow, SJ
Powers, BE
Manning, M
Citation: Vs. Bregazzi et al., Intracavitary slow release paclitaxel polymer in a rodent model of mammarycarcinoma, J BIOACT C, 15(1), 2000, pp. 85-88
Authors:
Mohan, R
Wu, QW
Manning, M
Schmidt-Ullrich, R
Citation: R. Mohan et al., Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers, INT J RAD O, 46(3), 2000, pp. 619-630
Authors:
Wu, QW
Manning, M
Schmidt-Ullrich, R
Mohan, R
Citation: Qw. Wu et al., The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study, INT J RAD O, 46(1), 2000, pp. 195-205
Authors:
Manning, M
Citation: M. Manning, A footprint test, PHYS SPORT, 28(1), 2000, pp. 29-29
Authors:
Chase, D
Manning, M
Morgan, JA
Nathanson, GM
Gerber, RB
Citation: D. Chase et al., Argon scattering from liquid indium: Simulations with embedded atom potentials and experiment, J CHEM PHYS, 113(20), 2000, pp. 9279-9287
Authors:
Cotte, N
Balestre, MN
Aumelas, A
Mahe, E
Phalipou, S
Morin, D
Hibert, M
Manning, M
Durroux, T
Barberis, C
Mouillac, B
Citation: N. Cotte et al., Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding, EUR J BIOCH, 267(13), 2000, pp. 4253-4263
Authors:
Hibert, M
Hoflack, J
Trumpp-Kallmeyer, S
Mouillac, B
Chini, B
Mahe, E
Cotte, N
Jard, S
Manning, M
Barberis, C
Citation: M. Hibert et al., Functional architecture of vasopressin/oxytocin receptors, J RECEPT SI, 19(1-4), 1999, pp. 589-596
Authors:
Manning, M
Stoev, S
Cheng, LL
Wo, NC
Chan, WY
Citation: M. Manning et al., Discovery and design of novel vasopressin hypotensive peptide agonists, J RECEPT SI, 19(1-4), 1999, pp. 631-644
Authors:
Stoev, S
Cheng, LL
Olma, A
Klis, WA
Manning, M
Sawyer, WH
Wo, NC
Chan, WY
Citation: S. Stoev et al., An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids, J PEPT SCI, 5(3), 1999, pp. 141-153
Authors:
Manning, M
Stoev, S
Cheng, LL
Wo, NC
Chan, WY
Citation: M. Manning et al., Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists, J PEPT SCI, 5(11), 1999, pp. 472-490
Authors:
Houry, D
Southall, J
Manning, M
Parsons, D
Citation: D. Houry et al., Use of the Amplatz thrombectomy device for severe deep venous thrombosis, SOUTH MED J, 92(9), 1999, pp. 915-917
Authors:
Manning, M
Junemann, KP
Weiss, J
Alken, P
Citation: M. Manning et al., Operative correction of penile deviation: Indications for and limitations of the Schroder-Essed-technique, AKT UROL, 30(3), 1999, pp. 163-169
Authors:
Manning, M
Haitsmann, V
Junemann, KP
Alken, P
Citation: M. Manning et al., Decline in testosterone blood concentration after testicular sperm (TESE) in non-obstructive azoospermia, AKT UROL, 30(1), 1999, pp. 41-45
Authors:
Morin, D
Cotte, N
Balestre, MN
Mouillac, B
Manning, M
Breton, C
Barberis, C
Citation: D. Morin et al., The D136A mutation of the V-2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities, FEBS LETTER, 441(3), 1998, pp. 470-475
Authors:
Morin, D
Cotte, N
Phalipou, S
Balestre, MN
Ala, Y
Sabatier, N
Jard, S
Vargas, R
Antignac, C
Dechaux, M
Arthus, M
Lonergan, M
Turner, MS
Bichet, DG
Hendy, GN
Alonso, G
Manning, M
Hibert, M
Mouillac, B
Barberis, C
Citation: D. Morin et al., The vasopressin V2 receptor: molecular basis of the nephrogenic diabetes insipidus and identification of residues responsible for binding selectivity, HYDRATION THROUGHOUT LIFE, 1998, pp. 215-221
Risultati:
1-24
|